Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-152469
Filing Date
2021-05-06
Accepted
2021-05-06 07:14:24
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d385293ds3.htm S-3 401073
2 EX-1.2 d385293dex12.htm EX-1.2 183398
3 EX-4.3 d385293dex43.htm EX-4.3 350179
4 EX-4.4 d385293dex44.htm EX-4.4 355857
5 EX-4.5 d385293dex45.htm EX-4.5 43659
6 EX-4.6 d385293dex46.htm EX-4.6 42198
7 EX-5.1 d385293dex51.htm EX-5.1 30978
8 EX-23.1 d385293dex231.htm EX-23.1 1744
9 GRAPHIC g385293g05f15.jpg GRAPHIC 39608
10 GRAPHIC g385293g95z43.jpg GRAPHIC 1896
  Complete submission text file 0001193125-21-152469.txt   1463782
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255806 | Film No.: 21895762
SIC: 2834 Pharmaceutical Preparations